# Replimune Group, Inc.: Form 8-K, filed Aug 8, 2024

- Company: [Replimune Group, Inc.](/companies/repl.md) (CIK 1737953)
- Form: 8-K
- Filed: 2024-08-08
- Accepted by EDGAR: Aug 8, 2024, 08:04 ET
- Period: 2024-08-08
- Accession: 0001104659-24-087035
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737953/000110465924087035/tm2421132d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737953/000110465924087035/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737953/000110465924087035/tm2421132d1_8k.htm

Filed Aug 8, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-087035. Last ingested by Listed: Nov 7, 2026, 12:41 ET. No prices; not investment advice.